F. Oeffner et al., Significant association between a silent polymorphism in the neuromedin B gene and body weight in German children and adolescents, ACT DIABETO, 37(2), 2000, pp. 93-101
Neuromedin B has been shown to exert an inhibiting effect on food consumpti
on in rats. The corresponding gene NMB maps to chromosome 15q22.3-q23, a re
gion expected to contain a gene for the Bardet-Biedl syndrome type 4 (BBS4)
. Based on its map position and the putative function of the encoded peptid
e, NMB can be considered as a candidate gene both for BBS4 and the developm
ent of human obesity. To examine its involvement in these phenotypes, we de
termined the genomic structure of human NMB, and performed a mutation scree
n in its coding region. In genomic DNA of six BBS4 patients and in a large
population sample, two sequence variants were detected: a g.253C-->A transv
ersion creating a P73T substitution and a g.401G-->A silent mutation changi
ng the stop codon TGA into stop codon TAA. A case-control study with 92 ext
remely obese patients and 94 underweight students revealed a significant as
sociation between the g.401G-->A polymorphism and body weight (adjusted p =
0.03), which was confirmed in a validation sample consisting of 95 extreme
ly obese patients, and 95 normal weight and 48 underweight individuals (Man
n-Whitney p = 0.02). These results suggest a contribution of NMB or a gene
in its close vicinity to genetic weight control in humans.